Abstract 404P
Background
Cancers in AYA is being recognized as a disenfranchised niche field with its own unique epidemiology, cancer biology, risk factors, treatment implications & the massive socio-economic impact it bears on this most economically productive age-group. There is a paucity of well-collated published data from developing countries. Our study has tried to compile & analyze the pattern of AYA cancers from a large rural tertiary care teaching-hospital in South India & compare it to the published national data.
Methods
We compiled & analyzed the burden of AYA cancers in terms of demographic & site distribution, proportion, histopathologic diagnosis & other parameters over Jan.2019 to Dec.2022 from the medical records of large rural tertiary care teaching-hospital in South India. We compared our data on AYA cancers vis-à-vis the published national statistics.
Results
A total of 7973 patients were diagnosed with cancer between Jan.2019 to Dec.2022, 983(12.3%) occurred in AYA. 544(55.3%) were females. 104(10.6%), 126(12.9%), 153(15.5%), 226(23%) & 374(38.0%) occurred in the 15-19, 20-24, 25-29, 30-34 & 35-39 age groups respectively. The most common cancer overall was hematolymphoid malignancy(201, 20.4%), followed by thyroid(188, 19.12%). The most common hematolymphoid malignancy is acute leukaemia followed by non-Hodgkin lymphoma. The most common thyroid neoplasm was papillary thyroid carcinoma. Other common malignancies included Breast(113, 11.5%), Oral cavity(79, 8%), Central nervous system(65, 6.6%) & lower gastrointestinal tract(48, 4.9%).
Conclusions
AYA cancers deserve organizational support, multicenter collaboration, & resource-appropriate treatment adaptations with dedicated survivorship clinics. Mapping the epidemiology of AYA cancers will help improve surveillance, further focussed research & collaboration, guide resource allocation and national health policies, thus ultimately improve survival.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Dr. Vishwapriya Mahadev Godkhindi.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
420P - Predictive factors of post-operative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
Presenter: Chito Cabiling
Session: Poster viewing 06
421P - The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy
Presenter: Deniz Can Guven
Session: Poster viewing 06
422P - Molecular mechanism in prostate cancer with TP53 mutation
Presenter: Bin Hu
Session: Poster viewing 06
423P - Maintaining a national essential medicine list for cancer in Malaysia: Where do we stand?
Presenter: David Lee
Session: Poster viewing 06
424P - The Storm: Paraneoplastic leucomoid reaction - A bad prognostic factor
Presenter: Abdullah Al Mamun Khan
Session: Poster viewing 06
425P - Preliminary study: Assessment of public trust in traditional medicine and medical treatment in cancer patients in Indonesia - Study validity and reliability of the Universitas Sebelas Maret Trust and readiness assessment for cancer patients (UNS – TRAfCP35) questionnaire
Presenter: Widyanti Soewoto
Session: Poster viewing 06
426P - Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
Presenter: Alexey Rumyantsev
Session: Poster viewing 06
427P - Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?
Presenter: Gayathri Kumar
Session: Poster viewing 06
428P - Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
Presenter: PRASHANT SIROHIYA
Session: Poster viewing 06
429P - Cancer and COVID-19 in India: Assessing the impact in a nationwide survey
Presenter: Bharti Devnani
Session: Poster viewing 06